Vitamin C Conditioning Generates Tumor-Targeting CAR T Cells with Superior Cytotoxicity and Fitness in a Posttransplant Lymphoproliferative Disorder Tumor Model
Year: 2025
Type: article
Language: en
Topic: CAR-T cell therapy research
Authors and affiliations:
raw_author_name: Pegah Rahmati
raw_affiliation_strings: Hannover Medical School 1 Institute of Transfusion Medicine and Transplant Engineering, , Hannover, Germany
Hannover Medical School Hannover Germany
raw_author_name: Agnes Bonifacius
raw_affiliation_strings: 2German Center for Infection Research (DZIF), Thematical Translation Unit-Immunocompromised Host (TTU-IICH), partner site Hannover-Braunschweig, Braunschweig, Germany
Hannover Medical School 1 Institute of Transfusion Medicine and Transplant Engineering, , Hannover, Germany
Hannover Medical School 3 nextGENERATION Medical Scientist Program, Dean’s Office for Academic Career Development, , Hannover, Germany
Hannover Medical School Hannover Germany
raw_author_name: Anna Christina Dragon
raw_affiliation_strings: Hannover Medical School 1 Institute of Transfusion Medicine and Transplant Engineering, , Hannover, Germany
Hannover Medical School 3 nextGENERATION Medical Scientist Program, Dean’s Office for Academic Career Development, , Hannover, Germany
Hannover Medical School Hannover Germany
raw_author_name: Chiara Malinconico
raw_affiliation_strings: Hannover Medical School 1 Institute of Transfusion Medicine and Transplant Engineering, , Hannover, Germany
Hannover Medical School Hannover Germany
raw_author_name: Friederike Floegel
raw_affiliation_strings: Hannover Medical School 1 Institute of Transfusion Medicine and Transplant Engineering, , Hannover, Germany
Hannover Medical School Hannover Germany
raw_author_name: Anne Halenius
raw_affiliation_strings: 5Faculty of Medicine, University of Freiburg, Freiburg, Germany
University Medical Center Freiburg 4 Institute of Virology, , Freiburg, Germany
University Medical Center Freiburg Germany
raw_author_name: Rainer Blasczyk
raw_affiliation_strings: Hannover Medical School 1 Institute of Transfusion Medicine and Transplant Engineering, , Hannover, Germany
Hannover Medical School Hannover Germany
raw_author_name: Britta Maecker-Kolhoff
raw_affiliation_strings: 2German Center for Infection Research (DZIF), Thematical Translation Unit-Immunocompromised Host (TTU-IICH), partner site Hannover-Braunschweig, Braunschweig, Germany
Hannover Medical School 6 Department of Pediatric Hematology and Oncology, , Hannover, Germany
Hannover Medical School Hannover Germany
raw_author_name: Michael Hudecek
raw_affiliation_strings: 8Fraunhofer Institute for Cell Therapy and Immunology, Branch Site Cellular Immunotherapy, Würzburg, Germany
University Hospital of Würzburg 7 Department of Internal Medicine II, , Würzburg, Germany
University Hospital Würzburg Würzburg Germany
raw_author_name: Stefan Floess
raw_affiliation_strings: Helmholtz Centre for Infection Research 9 Department Experimental Immunology, , Braunschweig, Germany
Helmholtz Centre for Infection Research Germany
raw_author_name: Jochen Huehn
raw_affiliation_strings: Helmholtz Centre for Infection Research 9 Department Experimental Immunology, , Braunschweig, Germany
Helmholtz Centre for Infection Research Germany
raw_author_name: Britta Eiz-Vesper
raw_affiliation_strings: 2German Center for Infection Research (DZIF), Thematical Translation Unit-Immunocompromised Host (TTU-IICH), partner site Hannover-Braunschweig, Braunschweig, Germany
Hannover Medical School 1 Institute of Transfusion Medicine and Transplant Engineering, , Hannover, Germany
Hannover Medical School Hannover Germany